INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 223 filers reported holding INSMED INC in Q1 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $355 | -15.7% | 14,048 | -29.6% | 0.03% | -18.2% |
| Q2 2023 | $421 | +15.0% | 19,953 | -7.1% | 0.03% | +22.2% |
| Q1 2023 | $366 | -19.9% | 21,479 | -6.2% | 0.03% | -28.9% |
| Q4 2022 | $457 | -99.9% | 22,897 | +19.3% | 0.04% | 0.0% |
| Q3 2022 | $413,000 | -0.2% | 19,185 | -8.7% | 0.04% | +2.7% |
| Q2 2022 | $414,000 | +45.3% | 21,006 | +73.4% | 0.04% | +311.1% |
| Q1 2022 | $285,000 | – | 12,116 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,533,883 | $44,590,000 | 16.02% |
| Foresite Capital Management II, LLC | 919,436 | $26,728,000 | 12.07% |
| NEXTHERA CAPITAL LP | 284,263 | $8,264,000 | 10.03% |
| Palo Alto Investors LP | 7,653,617 | $222,491,000 | 9.28% |
| Asymmetry Capital Management, L.P. | 154,887 | $4,503,000 | 7.52% |
| ACUTA CAPITAL PARTNERS, LLC | 370,000 | $10,756,000 | 5.11% |
| Vivo Capital, LLC | 1,170,290 | $34,020,000 | 3.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 110,000 | $3,198,000 | 1.18% |
| Islet Management, LP | 350,000 | $10,175,000 | 1.18% |
| EMERALD ADVISERS, LLC | 921,527 | $26,789,000 | 1.09% |